N,N'-((6-PHENOXY-1,3,5-TRIAZINE-2,4-DIYL)BIS(IMINO(9,10-DIHYDRO-9,10-DIOXOANTHRACENE-5,1-DIYL)))BIS(BENZAMIDE)
UNII MDD2Q4994U

Substance Identification & Data

This profile provides standardized clinical and technical data for N,n'-((6-phenoxy-1,3,5-triazine-2,4-diyl)bis(imino(9,10-dihydro-9,10-dioxoanthracene-5,1-diyl)))bis(benzamide), uniquely identified by the FDA Unique Ingredient Identifier (UNII) MDD2Q4994U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2469-87-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MDD2Q4994U

CAS Registry Number

2469-87-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N,N'-((6-PHENOXY-1,3,5-TRIAZINE-2,4-DIYL)BIS(IMINO(9,10-DIHYDRO-9,10-DIOXOANTHRACENE-5,1-DIYL)))BIS(BENZAMIDE)

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C51H31N7O7

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

UBZOMZRRLGXNJB-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

16197789

Unique identification number in the NCBI database of chemical substances.

Substance Type

N,N'-((6-Phenoxy-1,3,5-triazine-2,4-diyl)bis(imino(9,10-dihydro-9,10-dioxoanthracene-5,1-diyl)))bis(benzamide)

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c12C(c3cccc(c3C(c1cccc2NC(=O)c4ccccc4)=O)Nc5nc(nc(n5)Oc6ccccc6)Nc7c8C(c9cccc(c9C(c8ccc7)=O)NC(=O)c%10ccccc%10)=O)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N,n'-((6-phenoxy-1,3,5-triazine-2,4-diyl)bis(imino(9,10-dihydro-9,10-dioxoanthracene-5,1-diyl)))bis(benzamide). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.